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Abstract
Cell identity is a reflection of a cell type-specific gene expression
profile, and consequently, cell type-specific transcription factor
networks are considered to be at the heart of a given cellular
phenotype. Although generally stable, cell identity can be repro-
grammed in vitro by forced changes to the transcriptional network,
the most dramatic example of which was shown by the induction
of pluripotency in somatic cells by the ectopic expression of defined
transcription factors alone. Although changes to cell fate can be
achieved in this way, the efficiency of such conversion remains very
low, in large part due to specific chromatin signatures constituting
an epigenetic barrier to the transcription factor-mediated repro-
gramming processes. Here we discuss the two-way relationship
between transcription factor binding and chromatin structure
during cell fate reprogramming. We additionally explore the poten-
tial roles and mechanisms by which histone variants, chromatin
remodelling enzymes, and histone and DNA modifications contrib-
ute to the stability of cell identity and/or provide a permissive
environment for cell fate change during cellular reprogramming.
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Introduction
During the differentiation process, the developmental capacity of
totipotent cells in the early embryo is progressively lost as these
undertake cell fate decisions. This process is driven by the expres-
sion of cross-antagonistic transcription factors (TF) promoting
development towards one cell fate while repressing an alternative
differentiation path (Graf & Enver, 2009). Cell fate decisions are
fortified by progressive acquisition of complex layers of epigenetic
modifications at both the DNA and chromatin level (Goldberg et al,
2007; Xie et al, 2013; Ho et al, 2014). While cell identity is undeni-
ably dictated by the expression profile guided by cell type-specific
TFs (Davidson & Erwin, 2006), the robustness of the acquired
transcriptional state is additionally crucially dependent on the
configuration of the chromatin context in which these TFs operate
(Voss & Hager, 2014). As the key epigenetic modifications acquired
during developmental progression are stable and inherited through
subsequent cell divisions, an ‘epigenetic memory’ is established that
underlies the phenotypic stability of the differentiated cell state
(Zhu et al, 2013; Jost, 2014; Shipony et al, 2014).
Although generally stable in vivo, cell fate decisions can be
manipulated and even reversed, in vitro. The experimental demon-
stration that every cell of an organism contains the complete
genetic information, and that the acquired somatic state can be
reversed by exposing the somatic nucleus to the oocyte environ-
ment (Gurdon et al, 1958; Gurdon, 1960, 1962), set off a search for
mechanisms implicated in the erasure of epigenetic memory and
the re-establishment of pluri- or totipotency. It has subsequently
been shown that cell identity is also amenable to reprogramming
using cell fusion (Miller & Ruddle, 1976) and by overexpression of
master regulator TFs (Davis et al, 1987). Ultimately, reprogramming
of somatic cells back to pluripotency was achieved by the ectopic
expression of (only) four TFs (Takahashi & Yamanaka, 2006).
In agreement with the role of TFs and gene regulatory networks
in defining cell identity, reprogramming of cell fate requires extinc-
tion of the existing transcriptional programme followed by the
establishment and stabilisation of the transcriptional network
specific to the cell type of interest. It has, however, become increas-
ingly obvious that the successful reprogramming process entails,
and in fact requires, complete erasure of the existing somatic epige-
netic memory followed by the establishment of a new cell type-
specific epigenetic signature. Thus, although changes to cell identity
can be achieved by ectopic expression of key TFs alone, the effi-
ciency of conversion remains painfully low, with existing chromatin
modifications constituting a well-described barrier to the reprogram-
ming process (Mikkelsen et al, 2008; Pasque et al, 2012; Chen et al,
2013b; Gaspar-Maia et al, 2013; Sridharan et al, 2013).
Here we summarise the current knowledge regarding the
complex relationship between chromatin structure and reprogram-
ming of cell fate. We additionally consider whether epigenetic
changes are secondary to the newly established transcriptional
networks, or whether establishing a permissive chromatin template
is a necessary—or potentially even sufficient—step for cell repro-
gramming to occur.
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Transcription factors and chromatin structure:
a two-way relationship
In a model whereby TF cross-antagonism is the central mechanism
by which cell fate is determined, cell fate transitions, such as those
observed during de-differentiation and trans-differentiation events,
are possible through the ectopic expression of the required cell type
instructive TFs (Graf & Enver, 2009). The most extreme and best
studied example of this is the direct reprogramming of somatic cells
to induced pluripotent stem cells (iPSCs) through the ectopic expres-
sion of the pluripotency-associated TFs: Oct4, Sox2, Klf4, and Myc
(OSKM) (Takahashi & Yamanaka, 2006). The expression of these
TFs destabilises the transcriptional network of differentiated somatic
cells and induces the expression of the embryonic stem (ES) cell
transcriptional network that eventually leads to the establishment of
an ES-like phenotype (Adachi & Scholer, 2012; Niwa, 2014).
In addition to changing the transcriptional network, overexpres-
sion of the OSKM transcription factors during iPSC reprogramming
has been shown to induce large-scale chromatin changes that ulti-
mately lead to the establishment of a chromatin template highly simi-
lar to that of ES cells (Orkin & Hochedlinger, 2011; Liang et al, 2012;
Apostolou & Hochedlinger, 2013). Of note, the establishment of this
chromatin template appears to be finely regulated by OSKM expres-
sion levels: sustained high transgene levels appear to hinder the
proper establishment of specific (bivalent) chromatin marks during
the later stages of iPSC induction, while establishment of the normal
ESC-like epigenetic signature can be achieved upon lowering/attenu-
ating expression of the four transgenes at an intermediate point
during the induction process (Hussein et al, 2014; Tonge et al, 2014).
In general, TFs (including OSK) are known to reshape the
chromatin landscape in the regions where they bind, both by
enabling the binding of other TFs and through direct recruitment of
various histone modifiers (Mal & Harter, 2003; Ancelin et al, 2006;
Magnani et al, 2011; Zaret & Carroll, 2011; Soufi et al, 2012; Drouin,
2014; Sherwood et al, 2014) (Fig 1A). Moreover, the binding of TFs
is known to induce locus-specific DNA demethylation (Stadler et al,
2011; Feldmann et al, 2013). In accordance with these observations,
large-scale chromatin changes associated with iPS reprogramming
may be a secondary phenomenon that follows destabilisation of the
somatic transcriptional network and establishment of the new pluri-
potency network. The observed chromatin changes would thus not
themselves be directly implicated in the reprogramming process,
but rather would reflect successful establishment of the pluripotent
state they are associated with.
Contrary to this view, accumulating evidence points towards an
important role for chromatin in early stages of reprogramming. It
has been shown that the initial engagement of OSK factors during
iPS reprogramming is hindered by repressive histone modifications
(Soufi et al, 2012), and the failure to successfully establish new
gene regulatory networks in trans-differentiation experiments
clearly correlates with the presence of closed inaccessible chromatin
in the original somatic cell type (Cahan et al, 2014; Morris et al,
2014). Additionally, both repressive H3K9me2/3 histone methyla-
tion and the presence of 5mC have been documented to act as a
barrier to the reprogramming process (Mikkelsen et al, 2008; Lister
et al, 2011; Chen et al, 2013b; Sridharan et al, 2013). Considering
these observations, efficient reprogramming appears to require an
optimal chromatin configuration that not only allows for fast and
effective engagement of the introduced TFs, but additionally
promotes the exchange of chromosomal components, thus enabling
fast and efficient erasure of pre-existing DNA and histone modifica-
tions (Fig 1B).
Reprogramming requires opening of the compacted
somatic chromatin template
Developmental progression from a totipotent to a differentiated cell
is a gradual process accompanied by deposition of repressive
histone marks and by increasing chromatin compaction (Gifford
et al, 2013; Xie et al, 2013; Zhu et al, 2013). Successful iPS repro-
gramming thus requires removal of the somatic repressive chroma-
tin to allow for conversion to a highly dynamic pluripotent
chromatin state that is largely devoid of heterochromatin (Meshorer
et al, 2006). In agreement with this, accumulating evidence suggests
that chromatin remodelling complexes and selective deposition or
eviction of certain histone variants play important roles in the acqui-
sition and subsequent maintenance of the permissive pluripotent
chromatin state (Fig 2 and Table 1).
Chromatin remodelling factors
Multiple chromatin remodelling factors have been shown to regulate
both ES cell identity and somatic cell reprogramming by their
chromatin shaping activities. Of the SWI/SNF family of chromatin
remodelling factors, esBAF (Brm/Brg-associated factor in ES cells)
and Ino80 (inositol requiring 80) have been shown to be important
both for the maintenance of ES self-renewal and pluripotency, and
also for iPSC reprogramming (Ho et al, 2009b, 2011; Wang et al,
2014b). In ES cells, esBAF, as well as Ino80, co-localise genome-wide
with the pluripotency factors (Ho et al, 2009a; Singhal et al, 2010;
Wang et al, 2014b). The activity of these remodelling complexes
leads to the generation of open chromatin structure and is thought to
promote binding and transcriptional activity of the OSKM factors
during reprogramming (Singhal et al, 2010; Wang et al, 2014b). In a
similar manner, the CHD (chromodomain helicase DNA binding)
family remodelling factor, Chd1, is also required to maintain open
chromatin in ES cells and has been shown to be important for ES
cell self-renewal and pluripotency (Gaspar-Maia et al, 2009). Down-
regulation of Chd1 leads to accumulation of heterochromatin and
significantly reduces reprogramming efficiency (Gaspar-Maia et al,
2009). These results thus collectively indicate that the potential to
open chromatin, or to maintain a less compacted chromatin state, is
a prerequisite for the acquisition of pluripotency.
Contrary to the remodelling complexes implicated in the genera-
tion of open chromatin structure discussed above, the NuRD
(nucleosome remodelling deacetylase) complex contains histone
deacetylase activity implicated in gene repression. In the absence of
Mbd3, one of the core subunits of the complex, embryonic stem cells
exhibit LIF-independent self-renewal capacity associated with
elevated expression of pluripotency-related genes (Kaji et al, 2006;
Reynolds et al, 2012). Upon differentiation, Mbd3-null ES cells fail to
fully repress genes that are expressed in pre-implantation embryos,
which in turn leads to deficiency in lineage commitment (Kaji et al,
2006). Interestingly, Mbd3 depletion dramatically increases repro-
gramming efficiency and results in deterministic and synchronised
iPSC reprogramming (Rais et al, 2013), even in the absence of c-Myc
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or Sox2 (Luo et al, 2013). It has been suggested that Mbd3/NuRD
is recruited through direct interaction with OSKM transcription
factors to downstream OSKM target genes and counteracts their
reactivation during iPS induction. In the absence of Mbd3, this inhib-
itory effect is relieved, favouring re-activation of pluripotency genes
and leading to improved reprogramming efficiency (Rais et al,
2013). However, another recent study reported that Mbd3/NuRD is
required for efficient iPS generation from neural stem cells (NSC),
pre-iPS cells and epiblast-derived stem cells (EpiSCs) (dos Santos
et al, 2014). Although overexpression of Mbd3/NuRD does not have
any positive or negative effect on iPSC induction efficiency, com-
bined overexpression with Nanog improves both reprogramming
Chromatin remodelling
Changes to histone modifications
DNA demethylation
A Transcription factor binding can induce chromatin changes
B Chromatin changes enable transcription factor engagement 
Closed/DNase I-resistant chromatin
Repressive histone modifications
5-methylcytosine
Open/DNase I-sensitive chromatin
Active histone modifications
Unmethylated cytosine
RESISTANT STATE
STATE 1
STATE 2
Transcription factor
+ chromatin modifiers
CHROMATIN
REMODELLING
Transcription
factor
PERMISSIVE STATE
5-methylcytosine
Unmethylated cytosine
Active histone modificationsPromoter Enhancer 
Promoter Enhancer 
Promoter Enhancer Promoter Enhancer 
Repressive histone modifications
Figure 1. Relationship between transcription factors and chromatin configuration during cell reprogramming.
(A) Pioneer transcription factors (TFs) are known to reshape the chromatin landscape in the regions where they bind, both by enabling the binding of other TFs and
through direct recruitment of various histone modifiers. In addition, the binding of both pioneer and non-pioneer TFs is known to induce locus-specific DNA demethylation.
(B) Closed inaccessible chromatin in the original somatic cell type, marked by repressive histone modifications and DNA methylation, hinders the initial engagement of
reprogramming-associated TFs. In turn, the activity of chromatin-modifying enzymes results in a permissive chromatin configuration that allows for fast and effective
engagement of the introduced TFs, enabling efficient reprogramming.
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kinetics and efficiency, which is in stark contrast with previous
reports showing that overexpression of Mbd3 inhibits iPSC induction
(Luo et al, 2013; Rais et al, 2013). The reported difference may be
due to different induction methods and culture conditions used in
these studies; however, further investigation is required to clarify the
exact role of Mbd3/NuRD in iPSC generation.
Histone chaperones and variants
In support of the idea of open chromatin structure promoting
reprogramming, overexpression of the histone chaperone Asf1a
favours the maintenance of ES cell pluripotency and enhances iPS
induction efficiency from human adult dermal fibroblasts (hADFs).
Asf1 (anti-silencing factor 1A) non-selectively binds to an H3-H4
heterodimer and facilitates its import from the cytoplasm into the
nucleus thus directly regulating the availability of H3-H4 dimer for
turnover by the canonical histone H3.1/2-chaperone Caf-1 or by the
H3.3-chaperone Hira (Burgess & Zhang, 2013). Asf1a is also essen-
tial for acetylation of newly synthesised H3 at lysine 56 (H3K56ac)
(Burgess & Zhang, 2013; Gonzalez-Munoz et al, 2014), and it has
been suggested that Asf1a regulates the expression of core pluripo-
tency genes during reprogramming by increasing global H3K56
acetylation levels (Gonzalez-Munoz et al, 2014).
The incorporation of various histone variants into nucleosomes
has a marked impact on local chromatin structure and dynamics. In
the context of iPSC reprogramming, combined over-expression of
the histone variants TH2A and TH2B, which are normally enriched
in the oocyte and early embryo (Montellier et al, 2013; Shinagawa
et al, 2014), has been shown to enhance the efficiency of iPS gener-
ation ninefold. This effect is further enhanced by additional overex-
pression of the phosphorylation-mimic form of nucleoplasmin
(P-Npm), a factor implicated in chromatin remodelling and zygotic
gene activation following fertilisation (Shinagawa et al, 2014).
PERMISSIVE CHROMATIN ENABLING
CELL REPROGRAMMING
CLOSED, COMPACTED
CHROMATIN ACTING AS A BARRIER
TO CELL REPROGRAMMING
Removing somatic 
histone marks
H3K9me3
• Suv3h1/2
• Setdb1
H3K27me3
• Utx
• Jmjd3
H3K79me2
• Dot1l
H3K9me2
• G9a
• Glp (?)
H3K36me3
• Set2
• Kdm2a/b
DNA replication
Removing somatic
DNA modifications
5-methylcytosine
• Dnmt1
• Parp1
5-hydroxymethylcytosine
• Tet1
• Tet2
DNA replication
Chromatin opening and 
decompaction
SWI/SNF
• esBAF
• Ino80
CHD remodellers
• Chd1
Nurd complex
• Mbd3 (?)
Histone chaperones
• Asf1
Histone variants
• TH2A
• TH2B
• H2AX
• H3.3
• macroH2A
DNA replication
Establishing pluripotent
histone marks
H3K4me1/2/3
• Wdr5
H2AK119Ub
• PRC1
H3K27me3
• PRC2
Promoter Enhancer 
Promoter Enhancer 
Figure 2. Chromatin components and modifiers affecting reprogramming efficiency.
Reprogramming requires the establishment of permissive chromatin and is associated with chromatin opening and changes to histone and DNA modifications. Multiple
factors have been implicated in these processes: marked in green and red are factors whose presence/activity is associated with increased and decreased reprogramming
efficiency, respectively; marked in purple are those factors whose presence/activity has been shown to both increase and decrease reprogramming efficiency in a
context-dependent manner; factors whose influence on reprogramming requires further investigation are marked by (?).
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Table 1. The roles of chromatin modifiers during somatic cell reprogramming.
Category
Chromatin
modifiers Roles in reprogramming References
Histone
modifications
H3K4me2/3 Marks promoters and enhancers of pluripotency- or differentiation-associated
genes during initial steps of reprogramming
Ang et al (2011);
Koche et al (2011)
H3K9me2/3 Marks broad heterochromatin regions refractory to initial OSKM binding;
acts as an epigenetic barrier towards reprogramming
Soufi et al (2012); Chen et al (2013b);
Sridharan et al (2013); Matoba et al
(2014)
H3K27me3 Represses pluripotency-associated genes in somatic cells and differentiation-
associated genes in iPSCs
Mansour et al (2012)
H3K36me2/3 Marks promoter regions of early responsive (MET) genes and represses their
activation
Liang et al (2012)
H3K79me2 Marks transcriptionally active genes; acts as a barrier for efficient repression
of lineage-specific genes
Onder et al (2012)
Heterochromatin
proteins
HP-1c Impedes reprogramming by repressing Nanog reactivation Sridharan et al (2013)
Histone
modifiers
Wdr5 Enhances reprogramming by physically interacting with Oct4 and
maintaining H3K4me3 on pluripotency-associated gene promoters
Ang et al (2011)
SUV39H1/2 Enhances reprogramming by facilitating Oct4/Sox2 binding through H3K9me3
demethylation
Onder et al (2012)
G9a Inhibition or down-regulation of G9a enhances reprogramming by regulating
global H3K9me2/3 levels
Ma et al (2008); Shi et al (2008);
Chen et al (2013b); Sridharan et al
(2013)
Setdb1 (?) Down-regulation enhances reprogramming by facilitating H3K9me3 status
at core pluripotency genes in one study while opposite effect was observed
in another study
Onder et al (2012);
Chen et al (2013b)
Ehmt1 (?) Down-regulation enhances reprogramming by regulating global
H3K9me2/3 levels in one study but opposite effect was observed in another
study
Onder et al (2012); Sridharan et al
(2013)
PRC1 (Ring1,
Bmi1)
Down-regulation of Ring1 or Bmi1 reduces reprogramming efficiency, while
overexpression of Bmi1 enhances reprogramming efficiency by regulating
H3K27me3 levels
Pereira et al (2010); Moon et al
(2011); Onder et al (2012)
PRC2 (Ezh2,
Suz12, Eed)
Down-regulation of Ezh2, Suz12, or Eed reduces reprogramming efficiency,
while overexpression of Ezh2 enhances reprogramming efficiency by
maintaining H3K27me3 at lineage-specific genes
Pereira et al (2010); Buganim et al
(2012); Onder et al (2012);
Fragola et al (2013)
Utx Physically interacts with OSK; facilitates iPS formation by H3K27me3 de-
methylation at pluripotency-associated genes
Mansour et al (2012)
Jmjd3
(Kdm6b)
Depletion increases iPS generation efficiency while overexpression inhibits
reprogramming through up-regulating Ink4a/Arf locus expression by
H3K27me3 demethylation; also promotes degradation of PHF20 independent
of its demethylase activity
Zhao et al (2013)
Jhdm1a/b
(Kdm2a/b)
(?) Down-regulation reduces reprogramming efficiency, while overexpression
enhances reprogramming by activating early responsive (MET) genes and the
expression of microRNA cluster 302/367
Wang et al (2011); Liang et al (2012)
Dot1L Down-regulation enhances reprogramming by promoting the silencing of
lineage-specific genes through loss of H3K79me2
Onder et al (2012)
Chromatin
remodellers
MBD3/NuRD Down-regulation enhances reprogramming by facilitating the reactivation of
downstream OSKM target genes in one study, while opposite effect was
observed in another study
Rais et al (2013); dos Santos et al
(2014)
Ino80 Down-regulation leads to more closed chromatin structure near pluripotency
gene promoters and reduces reprogramming efficiency
Wang et al (2014b)
Chd1 Down-regulation leads to accumulation of heterochromatin and reduces
reprogramming efficiency
Gaspar-Maia et al (2009)
BAF (Brg1,
Baf155)
Brg1 and Baf155 synergistically increase reprogramming efficiency by
enhancing Oct4 binding and facilitating de-methylation of Oct4 and Nanog
promoters
Singhal et al (2010)
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Increased DNase I sensitivity upon forced expression of TH2A and
TH2B and the synergistic effect of P-Npm suggests that the enhance-
ment of somatic cell reprogramming occurs through the induction of
an open chromatin structure (Shinagawa et al, 2014).
Similarly, histone variant H3.3 counteracts linker histone H1-
mediated chromatin compaction, keeping diverse genomic sites in
an open chromatin conformation (Braunschweig et al, 2009). H3.3
incorporation into donor nuclei is required for successful somatic cell
nuclear transfer (SCNT) (Nashun et al, 2011; Jullien et al, 2012; Wen
et al, 2014), and down-regulation of histone H3.3 in mouse oocytes
leads to compromised reprogramming efficiency (Wen et al, 2014).
This appears to parallel the in vivo situation, where, following fertili-
sation, the selective incorporation of H3.3 into the paternal genome
by the H3.3-specific histone chaperone Hira is essential for its
de-condensation (Inoue & Zhang, 2014; Lin et al, 2014), and loss of
H3.3 leads to over-condensation during early embryonic development
(Lin et al, 2013). While Hira-mediated H3.3 deposition is required for
proper establishment of H3K27me3 at the promoters of developmen-
tally regulated genes in embryonic stem cells, depletion of H3.3 or
Hira has only minor transcriptional effects (Banaszynski et al, 2013).
The role of these factors during induction of pluripotency remains
largely unknown.
In comparison with TH2A, TH2B, and H3.3, macroH2A, with its
unique macro-domain, is associated with a repressive chromatin
state. In agreement with the open chromatin structure found in
pluripotent cells, the pluripotent state is associated with low
macroH2A levels that increase following cell differentiation (Creppe
et al, 2012). MacroH2A is abundant in differentiated somatic cells,
but disassociates immediately from somatic donor chromosomes
during SCNT (Chang et al, 2010). Recent studies indicated that
macroH2A acts as an epigenetic barrier to induced pluripotency: the
absence of this particular histone variant enhances iPSC reprogram-
ming up to 25-fold (Pasque et al, 2012), while its overexpression
prevents efficient reprogramming of epiblast stem cells to naı¨ve
pluripotency (Pasque et al, 2012; Barrero et al, 2013). It has
additionally been shown that macroH2A and H3K27me3 co-occupy
the regulatory regions of pluripotency genes in somatic cells
(Barrero et al, 2013; Gaspar-Maia et al, 2013). Although iPSCs
induced in the absence of this histone variant are able to differenti-
ate, they retain the ability to return to a stem cell-like state
(Gaspar-Maia et al, 2013) likely due to the incomplete inactivation
of pluripotent genes during differentiation (Creppe et al, 2012).
Recent reports have shed new light on a possible role of another
H2A histone variant in the reprogramming process. Ectopic
expression of reprogramming factors increases the level of
phosphorylated histone H2A.X, and high basal levels of c-H2A.X
have been observed in both iPSCs and ESCs, decreasing upon differ-
entiation (Banath et al, 2009; Turinetto et al, 2012). Depletion of
H2A.X reduces the efficiency of iPSC derivation (Wu et al, 2014)
and compromises self-renewal activity in ES cells (Turinetto et al,
2012). Although typically associated with the DNA damage
response, high c-H2A.X levels do not correlate with elevated levels
of DNA damage response proteins (Turinetto et al, 2012). Thus,
while these recent findings suggest that they play an important role
during reprogramming, the exact mechanism by which H2A.X or its
phosphorylated form (c-H2A.X) contribute to self-renewal and iPSC
reprogramming requires further investigation.
Changes in histone post-translational modification linked
to the reprogramming process
Early iPS reprogramming is marked by rapid acquisition of active
post-translational histone modifications
Rapid genome-wide changes of H3K4me2 distribution are one of
the earliest events observed in the initial phase of reprogramming
Table 1 (continued)
Category
Chromatin
modifiers Roles in reprogramming References
Histone variants H1foo Overexpression maintains the pluripotency gene expression and maintains global
low methylation status
Hayakawa et al (2012)
H2A.X Down-regulation of H2A.X completely inhibits iPS generation Wu et al (2014)
H3.3 H3.3 counteracts H1 binding, and down-regulation of H3.3 in oocyte leads to
compromised somatic cell reprogramming
Braunschweig et al (2009);
Wen et al (2014)
macroH2A Co-occupies pluripotency genes with H3K27me3 and acts as an epigenetic barrier
to induced pluripotency. Down-regulation significantly enhances iPS generation
Pasque et al (2012); Barrero et al
(2013); Gaspar-Maia et al (2013)
TH2A/B Co-overexpression enhances reprogramming by inducing an open chromatin
structure
Shinagawa et al (2014)
Histone
chaperones
ASF1A Overexpression enhances reprogramming by increasing global H3K56ac levels in
the presence of GDF9 in culture medium
Gonzalez-Munoz et al (2014)
DNA modifiers Dnmt1 Inhibiting activity by small molecules or knockdown significantly increases
reprogramming efficiency
Mikkelsen et al (2008)
TET1/2 Physically interacts and acts in synergy with Nanog. Oxidises 5mC in Oct4
regulatory elements, although the importance of this is unclear; induces
TDG-mediated demethylation at the mir200 cluster, which is necessary for
MET during fibroblast reprogramming
Doege et al (2012); Costa et al,
(2013); Gao et al (2013); Hu et al
(2014)
PARP1 Functions in the regulation of 5mC; promotes Oct4 accessibility to Nanog
and Esrrb loci
Doege et al (2012)
Dnmt3a/b Dispensable for nuclear reprogramming of somatic cells to pluripotent state Pawlak and Jaenisch (2011)
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(Koche et al, 2011). H3K4me2 peaks exhibit dramatic changes at
promoter and enhancer regions of more than a thousand genes,
including both pluripotency-related and developmentally regulated
loci. As positive H3K4me2 changes are observed on both pluripo-
tent and developmentally regulated genes (including those
expressed in MEFs), the observed initial histone modification
changes thus likely predominantly reflect chromatin accessibility.
Interestingly (and in line with above), H3K4me2 is targeted to the
pluripotency-associated genes before their transcriptional activa-
tion. Wdr5, the key component of Set/MLL histone methyltrans-
ferase complex responsible for H3K4 methylation, has been
shown to directly interact with Oct4 (Ang et al, 2011) and
promoters gaining H3K4me2 are significantly enriched for targets
of Oct4 and Sox2 (Koche et al, 2011). This interaction thus possi-
bly explains the rapid acquisition of H3K4 methylation early
during iPSC reprogramming at loci bound by ectopic Oct4.
Consistently, Wdr5 is required not only for ES cell self-renewal
but also for efficient reprogramming of somatic cells to pluripo-
tency (Ang et al, 2011).
Erasure and remodelling of repressive histone modifications
Although the initial observed epigenetic changes during the
reprogramming process are connected with the acquisition of
transcriptionally permissive histone marks (see above), the cumula-
tive evidence suggests that it is the erasure and remodelling of
repressive histone modifications that constitute the true barrier to
the reprogramming process.
H3K9me2/3 In stark contrast to H3K4me3-containing regions, broad
chromatin domains enriched for repressive H3K9me3 are refractory
to initial OSKM binding (Soufi et al, 2012). Reduction of H3K9me3
levels through down-regulation of methyltransferases Suv39H1&2
enhances Oct4 and Sox2 binding at these regions and increases
reprogramming efficiency (Onder et al, 2012; Soufi et al, 2012).
Consequently, H3K9me3-marked broad heterochromatin regions are
considered as an epigenetic barrier during somatic cell reprogram-
ming (Soufi et al, 2012; Chen et al, 2013b; Sridharan et al, 2013). In
support of this, a recent publication has also documented an inhibi-
tory role for H3K9me3 during reprogramming by SCNT (Matoba
et al, 2014). It should be however noted that the role of H3K9me3
in iPSC generation is context dependent, as the downregulation of
Setdb1, another H3K9me3 methyltransferase, has been reported to
both facilitate and impede reprogramming (Onder et al, 2012; Chen
et al, 2013b). In this context, it has been argued that H3K9me3 is
important for silencing of lineage-specific genes; consistently,
Setdb1 has been shown to repress trophectoderm-specific genes in
ES cells (Yeap et al, 2009; Yuan et al, 2009).
Next to H3K9me3, reduction of H3K9me2 through knockdown or
inhibition of G9a methyltransferase also favours somatic cell repro-
gramming both in transcription factor- and in cell fusion-based
reprogramming systems (Ma et al, 2008; Shi et al, 2008; Chen et al,
2013b; Sridharan et al, 2013). Contrary to G9a, the role of Ehmt1/
Glp (a binding partner of G9a) during iPSC generation remains
controversial (Onder et al, 2012; Sridharan et al, 2013).
H3K27me3 and PRC2 Large regions of metazoan chromatin contain-
ing developmentally regulated genes are silenced by H3K27me3
catalysed by polycomb repressive complex-2 (PRC2). In agreement
with the necessity to remove somatic heterochromatin patterns, loss
of H3K27me3 is observed during the earliest stages of reprogram-
ming yielding a transient open/primed chromatin state (Koche et al,
2011; Hussein et al, 2014; Tonge et al, 2014). The removal of
this repressive histone mark is likely mediated by Utx, a JmjC-
domain-containing enzyme that specifically mediates H3K27me2/3
demethylation (Klose et al, 2006). The importance of Utx in iPS
reprogramming is highlighted by greatly reduced reprogramming
efficiency and aberrant global H3K27me3 and H3K4me3 epigenetic
profiles in the iPS cells generated from Utx-depleted mouse embry-
onic fibroblasts (Mansour et al, 2012). Furthermore, complete
absence of Utx completely abolishes the ability of somatic cells to be
reprogrammed back to the ground state of pluripotency (Mansour
et al, 2012). While Utx physically interacts with OSK reprogram-
ming factors and removes the repressive mark from pluripotency-
promoting genes such as Fgf4, Sall4, and Sall1, Utx overexpression
does not increase the efficiency of iPSC formation, suggesting that it
does not represent a rate-limiting factor in the process (Mansour
et al, 2012). In contrast to Utx, Jmjd3 (Kdm6b), another histone
H3K27me3 demethylase, negatively regulates somatic cell repro-
gramming, highlighting the locus specificity and partially non-
overlapping functions of these enzymes. Depletion of Jmjd3 is
thought to reduce cell senescence by inhibiting Ink4a/Arf expression
through maintenance of H3K27me3 levels at its promoter, enhanc-
ing both the kinetics and efficiency of reprogramming (Zhao et al,
2013).
Although the somatic pattern of H3K27me3 needs to be erased
during the iPSC reprogramming, global loss of H3K27me3 through
down-regulation of Eed (resulting in loss of all PRC2 complexes)
leads to a severe decline in the efficiency of iPSC reprogramming
(Fragola et al, 2013); thus, silencing through H3K27me3 appears
indispensable for the establishment of iPSCs (Fragola et al, 2013).
Consistent with this idea, overexpression of the PRC2 catalytic
subunit Ezh2 enhances reprogramming efficiency (Buganim et al,
2012); down-regulation of other PRC2 complex components (Suz12
and Eed) significantly hinders iPSC generation (Onder et al, 2012);
and additional subunits of PRC2 in mouse ES cells (Jarid2, Mtf2 and
esPRC2p48) act synergistically to enhance OSK (Oct4/Sox2/Klf4)-
mediated mouse embryonic fibroblast reprogramming (Zhang et al,
2011). Moreover, components of the PRC1 complex, Ring1a and
Bmi1, are also required for efficient reprogramming, with the
combined overexpression of Bmi1 and Oct4 sufficient to induce
iPSCs from mouse fibroblasts (Moon et al, 2011). Finally, and of
note, PRC1 subunit Ring1b and PRC2 subunit Ezh2 are also required
for ES cells to efficiently reprogramme somatic cells in cell fusion-
based systems (Pereira et al, 2010).
Epigenetic changes linked to the memory of active
transcriptional state
One of the key steps during the reprogramming process is the extinc-
tion of the initial somatic transcriptional programme. Although the
expression of somatic genes is typically down-regulated early during
reprogramming (Brambrink et al, 2008; Stadtfeld et al, 2008; Polo
et al, 2012), stalled reprogramming intermediates often show
incomplete silencing of the somatic programme suggesting that the
maintenance of the original gene expression profile constitutes one
of the hurdles in the reprogramming process. From the chromatin
point of view, actively transcribed genes are characterised by
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Set2-mediated H3K36me2/3 and Dot1l-mediated H3K79me2 histone
modification marks present in gene bodies (Nguyen & Zhang, 2011;
Venkatesh et al, 2012). Down-regulation of either of these modifica-
tions by knockdown of the relevant histone methyltransferase
(Onder et al, 2012) or by an overexpression of the relevant histone
demethylase (Wang et al, 2011; Liang et al, 2012) prior to the iPS
reprogramming significantly enhances the reprogramming process.
On the molecular level, removal of these histone marks leads to the
efficient down-regulation of the original somatic transcription
profile, thus promoting cell fate change.
DNA modifications: 5-methylcytosine, 5-hydroxy-
methylcytosine and higher oxidative products
during reprogramming
Faithful reprogramming requires establishment of the
pluripotent methylome
In contrast to the high levels of DNA methylation consistently
observed in somatic cells, DNA methylation levels are low in the
naı¨ve pluripotent cells both in vivo (Mayer et al, 2000; Oswald et al,
2000; Smith et al, 2012, 2014; Guo et al, 2014; Wang et al, 2014c)
and in vitro (Ficz et al, 2013; Habibi et al, 2013; Leitch et al, 2013;
Takashima et al, 2014). Considering this, it has been suggested that
global DNA demethylation is a conserved and required feature of
reprogramming events (Hill et al, 2014).
The functional relationship between faithful transcriptome and
methylome reprogramming in iPSC and SCNT experimental systems
has been recently shown by Mitalipov and colleagues (Ma et al,
2014). Using genetically matched starting somatic cells, the authors
of this study used whole-genome bisulphite sequencing and RNA
sequencing to extensively compare the DNA methylomes and tran-
scriptomes of iPSC lines, ES cell lines generated through SCNT, and
ES cell lines generated through traditional in vitro fertilisation (IVF)
(Ma et al, 2014). They observed that both the DNA methylome and
transcriptome of SCNT-derived ES cell lines, where the somatic
nucleus was exposed to the cytoplasm of the host oocyte, were
highly similar to that of ES cell lines derived through IVF. In
contrast, iPSC reprogramming, involving only the ectopic expression
of reprogramming TFs, generated cell lines with both significant
differences in gene expression and high numbers of aberrantly
methylated regions (Ma et al, 2014). The study revealed a strong
correlation between incomplete reactivation of gene expression
during reprogramming and high promoter methylation in iPSCs (Ma
et al, 2014), suggesting that incomplete demethylation during iPSC
reprogramming may be responsible for the observed incomplete
transcriptional reprogramming.
DNA methyltransferase activity inhibits reprogramming efficiency
Studies investigating the direct relationship between DNA methyl-
ation and reprogramming efficiency have revealed that inhibition
of global DNA methyltransferase activity through addition of
5-azadC to growth medium or targeted knockdown of the mainte-
nance DNA methyltransferase Dnmt1 greatly increases reprogram-
ming efficiency (Mikkelsen et al, 2008) (Fig 2 and Table 1). In
contrast, the reprogramming potential of somatic cells depleted of
the de novo methyltransferases Dnmt3a and Dnmt3b appeared
largely unaffected (Pawlak & Jaenisch, 2011). These observations
suggest that, while maintenance of the somatic methylome is a
barrier that must be overcome, de novo deposition of methylation
is not a requirement for successful iPSC reprogramming. In fact,
the observation that the large majority of differentially methylated
regions (DMRs) between iPSCs and IVF ES cells do not overlap
DMRs between donor somatic cells and IVF ES cells suggest that
de novo DNA methylation may potentially contribute to the aber-
rant transcriptional profiles observed in iPSCs (Ma et al, 2014).
Combined, these observations suggest that faithful reprogramming
of the methylome may be a rate-limiting step to successful cell
reprogramming. Consistent with such a model, deposition of
H3K4me2 in the earliest stages of iPSC reprogramming only
occurs at promoters that are already hypomethylated in the
somatic nucleus, while acquisition of H3K4me2 at hypermethylated
somatic promoters appears to be an event restricted to late stages
of iPSC reprogramming, presumably following DNA demethylation
at these regions (Koche et al, 2011).
Context-specific requirement for Tet enzymes and oxidation of
5-methylcytosine oxidation in reprogramming
The recently discovered Tet family of oxygenases (Tet1-3), which
catalyse the oxidation of 5-methylcytosine (5-mC) to 5-hydroxy-
methylcytosine (5-hmC), 5-formylcytosine (5-fC), and 5-carboxycyto-
sine (5-caC) through iterative rounds of oxidation (Tahiliani et al,
2009; He et al, 2011; Ito et al, 2011), have been implicated in
reprogramming processes in vivo and in vitro, as we have recently
reviewed (Hill et al, 2014).
In the context of iPSC generation, Tet proteins were originally
identified as key mediators of reprogramming, as depletion of Tet1
and Tet2 resulted in significantly reduced efficiency of iPSC colony
formation (Doege et al, 2012; Chen et al, 2013a; Costa et al, 2013;
Gao et al, 2013; Hu et al, 2014). While it was originally suggested
that Tet1-mediated 5-hmC formation was required for Oct4 reactiva-
tion through demethylation of Oct4 regulatory elements (Gao et al,
2013), later studies were unable to reproduce these results (Hu et al,
2014). Further investigation revealed that Tet proteins are only
necessary for somatic cells to undergo the mesenchymal-to-
epithelial transition (MET) during iPSC reprogramming (Hu et al,
2014). Tet1-3 triple knockout somatic cells of epithelial morphology,
and fibroblasts acutely depleted of all three Tet proteins only follow-
ing MET, could both be efficiently reprogrammed to iPSCs (Hu et al,
2014). Further characterisation of the involvement of Tet proteins
during MET revealed that Tet2 mediates the oxidation of 5mC at the
MET-regulating mir200 microRNA cluster, resulting in DNA deme-
thylation and expression of the relevant microRNAs (Hu et al,
2014).
By comparison, the role of Tet proteins and 5-hmC in other in
vitro reprogramming systems is less well characterised. A require-
ment for Tet2 has been described for reactivation of the somatic
pluripotency-associated genes Oct4, Nanog, and Cripto during cell
fusion experiments, although the mechanism by which this is
achieved, and whether this is dependent on 5-hmC formation, is still
unclear (Piccolo et al, 2013). Similarly, oocyte-derived Tet3 has
been implicated in demethylation and reactivation of the somatic
Oct4 promoter in SCNT experiments (Gu et al, 2011). More experi-
mental work remains to be done to understand the relative impor-
tance of Tet proteins and 5-mC oxidation for both cell fusion and
SCNT reprogramming systems.
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DNA replication and cell division: a window of
permissive chromatin?
Considering the stability of heterochromatin and its restrictive role
in the reprogramming process, it is important to consider that cells
undergo dynamic cell cycle-associated chromatin changes with the
existing chromatin structure disrupted by passage of the replication
fork during S phase (MacAlpine & Almouzni, 2013). In view of this,
studies investigating the effect of cell cycle and cell division on
reprogramming can provide additional functional insights into the
role of chromatin structure in the reprogramming process. Using
cells in distinct stages of the cell cycle, Boiani and colleagues and
Fisher and colleagues definitively identified DNA synthesis in the
somatic nucleus as an essential requirement for reprogramming in
both SCNT (Wang et al, 2014a) and cell fusion (Tsubouchi et al,
2013) experimental systems. Consistently, early analysis of iPSC
reprogramming mechanisms revealed that increased cell division
rates achieved through down-regulation of the p53/p21 pathway or
over-expression of Lin28 markedly accelerated reprogramming
(Hanna et al, 2009), suggesting that increased frequency of cell
cycling is associated with accelerated iPSC reprogramming.
It remains to be fully understood why DNA synthesis is a pre-
requisite for reprogramming by cell fusion or SCNT (Tsubouchi
et al, 2013; Wang et al, 2014a), or why accelerated cell division
decreases the latency time of iPSC reprogramming (Hanna et al,
2009). One potential hypothesis considers the complex nature of
chromatin replication during S phase. As mentioned above, an
immediate consequence of DNA replication (and consequently cell
division) is the disruption of the existing chromatin structure by
passage of the replication fork (Alabert & Groth, 2012; MacAlpine &
Almouzni, 2013). For faithful re-establishment of the parental epige-
nome, a link must exist between the DNA replication fork and the
factors that propagate DNA modifications, histone modifications,
the correct incorporation of histone variants and other non-histone
chromatin proteins (Alabert & Groth, 2012; MacAlpine & Almouzni,
2013). Although the mechanisms for maintenance of DNA methyla-
tion patterns are relatively well understood, the abundance of
histone modifications seems to fluctuate with progression through
the cell cycle (Bonenfant et al, 2007). It is thus conceivable that
chromatin changes associated with S phase can provide a window
of opportunity for the ectopic TFs to bind their response elements.
Additionally, over the course of a number of cell divisions, minor
stochastic disruptions to the epigenetic inheritance could result in
additional loss of epigenetic memory. In the context of differentiated
cell states with robust transcriptional networks, minor disruptions
would not likely result in overt phenotypic changes. However, upon
exposure of the somatic nucleus to the pluripotent TFs (either
through ectopic expression of the iPSC reprogramming factors, cell
fusion, or SCNT), errors in the maintenance of epigenetic informa-
tion and aberrant DNA accessibility may facilitate the recruitment of
pioneer factors to regions normally recalcitrant to their binding
(Soufi et al, 2012), or, more generally, of non-pioneer pluripotency-
associated TFs to their DNA targets (Sherwood et al, 2014).
Conclusions: is a permissive chromatin template sufficient
for reprogramming in the absence of ectopic expression of
instructive transcription factors?
The model whereby the presence of cell type-specific TFs is the
central mechanism by which cell fate is determined, and chromatin
structure simply regulates the probability that TFs bind their geno-
mic targets, suggests that reprogramming to pluripotency can only
be induced when the somatic nucleus is exposed to the pluripotent
TFs (through ectopic iPSC factor expression, cell fusion, or SCNT).
According to this model, simple disruption of the underlying chro-
matin structure would be insufficient to drive reprogramming alone.
Remarkably, however, it has recently been shown that full repro-
gramming of somatic cells can be achieved in the absence of forced
TF overexpression through chemical manipulation of signalling
pathways and epigenetic modifiers alone (Hou et al, 2013). It
should be noted that reprogramming in the absence of instructive
TFs is likely only possible when cells are being reprogrammed back
to pluripotency, as trans-differentiation would ultimately depend on
Cell fate
restriction
Chromatin
plasticity
?
A B C
Figure 3. Is transition through a state characterised by open, dynamic chromatin a pre-requisite for all cell fate transitions?
(A) Reprogramming to pluripotency appears to require increased chromatin plasticity. (B, C) Possible relationship between chromatin dynamics and trans-differentiation:
(B) trans-differentiation via an upstream progenitor may be connected with a transient increase in chromatin permissiveness, and/or (C) direct trans-differentiation
between two somatic states without transition through an intermediary state characterised by more plastic chromatin may be possible, although this has yet to be
experimentally validated.
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the presence of lineage specifying TFs. Additionally, the presence of
specific culture conditions (e.g. agonists or antagonists of specific
signalling pathways) potentially compensates in part for the absence
of ectopic OSKM expression by providing a selective ‘environment’
during the reprogramming process. Nevertheless, with these caveats
in mind, the ability to reprogramme somatic cells in the absence of
instructive TFs clearly shows that it is possible to induce cell fate
reversal by synergistically destabilising the chromatin template and
the existing transcriptional network (using inhibitors of signalling
pathways). Although most of our current understanding regarding
chromatin dynamics during reprogramming stems from reprogram-
ming back to pluripotency using the iPSC reprogramming system, the
reached conclusions seem relevant also for trans-differentiation
experiments, where manipulation of chromatin accessibility/dynam-
ics might be an important factor to consider next to the establishment
of the relevant gene regulatory network. In this context, trans-
differentiation studies have documented that reprogramming
somatic cells directly to a cell of another somatic fate involves de-
differentiation and passage through a less differentiated progenitor
state (Xie et al, 2004) (Fig 3). While this progenitor state is likely to
be characterised by a more plastic chromatin configuration, whether
transitioning through a more open dynamic chromatin state during
the intermediary steps of trans-differentiation is an absolute pre-
requisite for cell fate change, or whether this appears to be a unique
requirement for reprogramming to pluripotency, will have to be
addressed in future work (Fig 3).
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